Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. - Wikidata - wikimedia - TriplyDB

Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.

Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.

http://www.wikidata.org/entity/Q34516318

about

House dust mite reduction and avoidance measures for treating eczema Non-pharmacologic therapies for atopic dermatitis.Atopic and non-atopic eczema.What causes worsening of eczema? A systematic review.New treatments for atopic dermatitis.Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches Environmental prevention in atopic eczema dermatitis syndrome (AEDS) and asthma: avoidance of indoor allergens.The role of topical calcineurin inhibitors in atopic dermatitis.Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment.Atopic dermatitis prevention.Atopic eczema: what's new?The indoor level of house dust mite allergen is associated with severity of atopic dermatitis in children.Debates in allergy medicine: specific immunotherapy efficiency in children with atopic dermatitis.Evaluation of the child with atopic dermatitis.Evaluation of the adult patient with atopic dermatitis.House dust mite reduction in the management of atopic dermatitis. A critically appraised topic.Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.Current eczema in children is related to Der f 1 exposure but not to Der p 1 exposure.Clinical Features of Atopic Dermatitis in Adults Are Different according to Onset.Sensitization to aeroallergens in atopic dermatitis patients: association with concomitant allergic diseases.The role of airborne proteins in atopic dermatitis.Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.Allergen immunotherapy in atopic dermatitis.Defining and Measuring the Scope of Atopic Dermatitis.Anti-allergic mattress covers in asthma: to do or not to do?Atopiclair

P2860

Q24186585-2BB5A571-760E-4F57-AFB0-36721581301B Q34359547-653DF219-7734-43F7-92D1-83F7B4987822 Q34441292-6548C289-7F3A-4CA9-9D70-3C8F4B5F3507 Q34557650-D115BAE9-9FAB-40B8-95B2-469963B006C8 Q34592295-D252CFCF-61BF-40F6-89CF-977E54BFDD76 Q35603170-15EFE5A5-45A6-40A7-A69C-88800C1519D8 Q35831636-4DC65642-53D4-43CA-82B9-656483D7CC1E Q35952647-10EF459C-32FB-4206-AF23-9B612DA39AF1 Q36214247-DF322246-9F28-44F6-A95A-0B4E8CFA7E75 Q36466794-4798FE2A-80F0-49DD-9835-0A06BA3AB995 Q36473293-6288C63B-D786-4EE9-A8A2-3918A53150FC Q36536360-DFD9343B-0AC5-4A3B-88DB-52BD52B39B6C Q36811415-7AF55835-510C-41EF-BBBB-4269EA184195 Q37957299-2197C9C1-6EFB-4951-9A14-781F5FC190A0 Q38081993-58CF2C87-5FF5-4C6D-84F3-0B2AF69E606D Q38092907-F50BAB8E-4181-4B05-9164-59363907B4C5 Q38807878-AEC4EE68-5B00-4A48-83FA-BEA0DCC20B90 Q38933737-2EBED6EE-0F52-47B2-94A1-F09EBB129163 Q40489098-75D4737E-6D28-46B9-BFBB-2D56068358FE Q40981478-B3812862-A6F7-41BB-AFE6-52AAA846DDAB Q41709222-9A2EC6AF-7AB3-480F-84F3-F294D9EB1CDC Q42217684-809A40BD-33F6-448B-A366-B79A6BF8CD2D Q42631175-16DA713E-9A85-4B17-A302-A9C40AFC2365 Q43067638-387D945F-BEE3-421E-9D5F-934816C486BD Q46436445-AEB7A2DD-8B46-4A7F-8290-22FBFB280A1A Q46918564-042E8C70-E3CA-4115-9E61-F8310857F894 Q47644708-DD3AE050-A678-483A-AFB3-0813A01047DA Q50074348-ADB1E4D4-86B4-4451-B1EC-163A03D9ACB7 Q51789423-CF690037-DC32-4303-9FE9-724C3C17CAEC Q56990853-CA1AD422-571D-4A7A-AB0F-23D8E445DBE4

P2860

Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.

http://www.wikidata.org/entity/Q34516318

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@ast

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@en

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@nl

type

label

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@ast

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@en

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@nl

prefLabel

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@ast

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@en

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@nl

P1433

Q34516318-175ACA80-37F1-461E-A837-13DA61D301E4

P1476

Q34516318-934D78B8-27FD-403E-A9AD-F65B435F87AD

P2093

Q34516318-449D838C-2E25-4F9F-94B4-3F09770918E7

Q34516318-4B03BBAB-8D01-465C-8A95-720B8C8354B8

Q34516318-4B8ED635-27B9-4AEB-A1AF-B4A1D5D3F264

Q34516318-66E2CE97-5935-406C-9709-8D920E81F9E6

Q34516318-BEF8721C-E342-4B8F-BE51-897D6954DF85

Q34516318-C85D7BB7-62EB-4935-B93D-334A62B3E0FB

Q34516318-DD51D8F9-35FC-47ED-B53D-BB6A2D52B9CD

P2860

Q34516318-0CBC4667-8423-43E3-B9DA-D17931630B3D

Q34516318-5EA0193D-41DA-435E-A8DD-861DA9EB07E5

Q34516318-6DB6DB1D-6565-4C15-863F-169D790140DF

Q34516318-75D21C82-3D13-4D44-966F-142E91C3AFFD

Q34516318-8E1D7E37-4BCD-425C-A02D-F82429A6DC00

Q34516318-DA053DD4-107D-454D-BF66-5AD710BB9FFA

P304

Q34516318-656315D5-EB2A-4321-9044-9FD99AA58028

P31

Q34516318-469BDA87-40E2-4D56-8954-68168A5B7415

P356

Q34516318-2FCB3A28-F7A0-41F8-AB80-7CA2A067C02E

P407

Q34516318-EEE48244-460F-4DB8-B946-03A4ABDC0747

P433

Q34516318-4CD93764-DF79-4F26-B56C-D365724C9B1D

P478

Q34516318-F0E4C1A1-B0B5-47D1-9A8C-BD110DE17781

P577

Q34516318-259C1999-BA1F-4415-AE53-51D52F133744

P698

Q34516318-0F3BD526-B475-4C89-98D7-C6EC18D238A7

P921

Q34516318-5289A5B9-9B8D-4E31-8A44-CB9FA3C5656B

P356

J.1365-2133.2001.04283.X

P1433

British Journal of Dermatology

P1476

Double-blind placebo-controlle ...... tients with atopic dermatitis.

@en

P2093

Brunner E

http://www.w3.org/2001/XMLSchema#string

Domhof S

http://www.w3.org/2001/XMLSchema#string

Gutgesell C

http://www.w3.org/2001/XMLSchema#string

Heise S

http://www.w3.org/2001/XMLSchema#string

Neumann C

http://www.w3.org/2001/XMLSchema#string

Seubert A

http://www.w3.org/2001/XMLSchema#string

Seubert S

http://www.w3.org/2001/XMLSchema#string

P2860

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

House dust mite exposure as a risk factor for asthma: benefits of avoidance.

House dust mite control measures in the management of asthma: meta-analysis.

Can house dust mite-triggered atopic dermatitis be alleviated using acaricides?

The 'atopy patch test' in evaluating the role of aeroallergens in atopic eczema.

House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test.

P304

70-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2133.2001.04283.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11453909

http://www.w3.org/2001/XMLSchema#string

P921